journal article·2014-01

In vitro macrophage response to nanometer‐size chromium oxide particles

Robilyn VanOs, Levannia L. Lildhar, Eric A. Lehoux, Paul E. Beaulé, Isabelle Catelas

Publisher page

Abstract

Abstract An increasing number of studies have reported adverse tissue reactions around metal‐on‐metal (MM) hip implants. However, the origin and mechanisms of these reactions remain unclear. Moreover, the biological effects of nanometer‐size chromium oxide particles, the predominant type of wear particles produced by MM implants, remain mostly unknown. The purpose of this study was to analyze the cytotoxic effects of clinically relevant nanometer‐size chromium oxide particles on macrophage response in vitro. J774.A1 macrophages were cultured with either 60 nm or 700 nm commercially available Cr2O3 particles at different concentrations. Two different particle sizes were analyzed to evaluate potential volume effects. Cell mortality was analyzed by light microscopy, flow cytometry (annexin V‐fluorescein isothiocyanate and propidium iodide assay), and using a cell death detection enzyme‐linked immunosorbant assay (ELISA). Tumor necrosis factor alpha (TNF‐α), monocyte chemotactic protein‐1 (MCP‐1), and macrophage inflammatory protein‐1 alpha (MIP‐1α) release was measured by ELISA, and gene expression was analyzed by quantitative real‐time PCR. Results showed that, at high concentrations, Cr2O3 particles of both sizes can be cytotoxic, inducing significant decreases in total cell numbers and increases in necrosis. Results also suggested that these effects were dependent on particle volume. However, TNF‐α, MCP‐1, and MIP‐1α cytokine release and gene expression remained low. Overall, this study demonstrates that nanometer‐size particles of Cr2O3, a stable form of chromium oxide ceramic, have rather low cytotoxic effects on macrophages. Therefore, these particles may not be the main culprit in the initiation of the inflammatory reaction in MM periprosthetic tissues. However, other parameters (e.g., potential intracellular damage) remain to be investigated. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 149–159, 2014.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Orthopedic Infections and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Mechanical Engineering University of Ottawa, Ottawa Ontario K1N 6N5 Canada

Department of Biochemistry Microbiology and Immunology, University of Ottawa Ottawa Ontario K1H 8M5 Canada

Division of Orthopaedic Surgery Department of Surgery University of Ottawa Ottawa Ontario K1H 8L6 Canada

References (57)

Show source-provided references
1. 10.1302/0301-620X.90B7.2021310.1302/0301-620X.90B7.20213 ↗
2. 10.1302/0301-620X.91B12.2228710.1302/0301-620X.91B12.22287 ↗
3. 10.1007/s11999-010-1372-y10.1007/s11999-010-1372-y ↗
4. 10.1080/00016470232102276710.1080/000164702321022767 ↗
5. 10.1097/00003086-199608001-0001710.1097/00003086-199608001-00017 ↗
6. 10.1016/S0142-9612(03)00378-810.1016/S0142-9612(03)00378-8 ↗
7. 10.1002/1097-4636(200009)53:5<480::AID-JBM6>3.0.CO;2-B10.1002/1097-4636(200009)53:5<480::AID-JBM6>3.0.CO;2-B ↗
8. 10.1088/1748-6041/4/2/02501810.1088/1748-6041/4/2/025018 ↗
9. 10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.0.CO;2-M10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.0.CO;2-M ↗
10. 10.1002/jbm.a.1008810.1002/jbm.a.10088 ↗
11. 10.1002/jbm.b.2003610.1002/jbm.b.20036 ↗
12. 10.1243/09544119JEIM11210.1243/09544119JEIM112 ↗
13. 10.1002/jbm.a.3230110.1002/jbm.a.32301 ↗
14. Serum cobalt levels after metal‐on‐metal total hip arthroplasty10.2106/00004623-200311000-00017 ↗
15. 10.1302/0301-620X.85B6.1416610.1302/0301-620X.85B6.14166 ↗
16. 10.1097/00003086-200301000-0003910.1097/00003086-200301000-00039 ↗
17. 10.1016/0142-9612(96)00072-510.1016/0142-9612(96)00072-5 ↗
18. 10.1016/S0142-9612(02)00351-410.1016/S0142-9612(02)00351-4 ↗
19. 10.1016/j.biomaterials.2004.08.00410.1016/j.biomaterials.2004.08.004 ↗
20. 10.1016/S0142-9612(02)00360-510.1016/S0142-9612(02)00360-5 ↗
21. 10.1002/jor.2060710.1002/jor.20607 ↗
22. 10.1002/jbm.a.3146710.1002/jbm.a.31467 ↗
23. 10.1016/j.bone.2009.05.02010.1016/j.bone.2009.05.020 ↗
24. 10.1002/jor.2091410.1002/jor.20914 ↗
25. 10.1016/j.mrgentox.2010.01.01210.1016/j.mrgentox.2010.01.012 ↗
26. 10.1016/S0142-9612(98)00214-210.1016/S0142-9612(98)00214-2 ↗
27. 10.1016/S0736-0266(01)00077-810.1016/S0736-0266(01)00077-8 ↗
28. 10.1097/00003086-199704000-0001710.1097/00003086-199704000-00017 ↗
29. 10.1023/A:101125402986410.1023/A:1011254029864 ↗
30. 10.1155/2012/59687010.1155/2012/596870 ↗
31. 10.1177/175342591245177910.1177/1753425912451779 ↗
32. 10.1243/095441197153430410.1243/0954411971534304 ↗
33. 10.1302/0301-620X.81B1.081015510.1302/0301-620X.81B1.0810155 ↗
34. 10.1097/BLO.0b013e31804b414710.1097/BLO.0b013e31804b4147 ↗
35. 10.1002/jbm.b.3099210.1002/jbm.b.30992 ↗
36. 10.1002/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.0.CO;2-I10.1002/(SICI)1097-4636(19980915)41:4<600::AID-JBM12>3.0.CO;2-I ↗
37. 10.1002/1097-4636(200011)52:2<296::AID-JBM8>3.0.CO;2-910.1002/1097-4636(200011)52:2<296::AID-JBM8>3.0.CO;2-9 ↗
38. 10.1302/0301-620X.84B2.1206110.1302/0301-620X.84B2.12061 ↗
39. 10.1007/s10856-009-3834-x10.1007/s10856-009-3834-x ↗
40. 10.1016/j.biomaterials.2007.06.01410.1016/j.biomaterials.2007.06.014 ↗
41. 10.1016/j.biomaterials.2010.03.04610.1016/j.biomaterials.2010.03.046 ↗
42. 10.2106/00004623-199306000-0000210.2106/00004623-199306000-00002 ↗
43. VanOs Robilyn · 2011
44. 10.1002/jor.110015010710.1002/jor.1100150107 ↗
45. Possible upregulation of macrophage responsiveness to wear debris
46. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition andremoval by macrophages10.4049/jimmunol.148.7.2207 ↗
47. 10.1084/jem.182.5.154510.1084/jem.182.5.1545 ↗
48. 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.0.CO;2-N10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.0.CO;2-N ↗
49. 10.1002/jbm.82028011110.1002/jbm.820280111 ↗
50. 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-710.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7 ↗
51. 10.1243/095441105X6329110.1243/095441105X63291 ↗
52. 10.2106/JBJS.J.0187710.2106/JBJS.J.01877 ↗
53. 10.1002/jor.110013052010.1002/jor.1100130520 ↗
54. 10.1016/S0142-9612(02)00032-710.1016/S0142-9612(02)00032-7 ↗
55. 10.1016/S0736-0266(02)00099-210.1016/S0736-0266(02)00099-2 ↗
56. 10.1016/j.arth.2007.05.04310.1016/j.arth.2007.05.043 ↗
57. 10.1016/j.actbio.2011.04.01110.1016/j.actbio.2011.04.011 ↗